Market Risers: Metal Tiger PLC, GlaxoSmithKline plc, Legal & General Group Plc, Burberry Group plc, Whitbread plc & Shire PLC

Metal Tiger Plc
[shareaholic app="share_buttons" id_name="post_below_content"]

Stock in Metal Tiger PLC company symbol: LON:MTR has gained 3.55% or 0.04 points throughout the session so far. Market buyers are a positive bunch throughout the trading session. Range high for the period has seen 1.29 dipping to 1.23. Volume total for shares traded during this period was 1,588,096 while the daily average number of shares exchanged is 5,384,855. The 52 week high for the share price is 3.44 amounting to 2.21 points different to the previous business close and a 52 week low sitting at 1.2 which is a variance of 0.03 points. Metal Tiger PLC now has a 20 moving average of 1.57 and now its 50 day moving average now of 1.85. The market cap now stands at £17.05m at the time of this report. Share price is traded in GBX. Mcap is measured in GBP. This article was written with the last trade for Metal Tiger PLC being recorded at Wednesday, December 19, 2018 at 11:14:30 AM GMT with the stock price trading at 1.27 GBX.

 

Shares of GlaxoSmithKline plc ticker code: LON:GSK has stepped up 7.53% or 109 points during today’s session so far. Buyers have so far held a positive outlook while the stock has been in play. The period high was 1567.8 dropping as low as 1503. Volume total for shares traded during this period was 7,373,588 with the daily average number around 12,925,344. The 52 week high price for the shares is 1648.8 which is 200.6 points difference from the previous days close and putting the 52 week low at 1179.39 which is a variance of 268.81 points. GlaxoSmithKline plc now has a 20 moving average of 1538.1 and now its 50 day moving average at 1540.38. This puts the market cap at £77,225.97m at the time of this report. The currency for this stock is GBX. Market cap is measured in GBP. This article was written with the last trade for GlaxoSmithKline plc being recorded at Wednesday, December 19, 2018 at 12:03:34 PM GMT with the stock price trading at 1557.2 GBX.

 

Shares of Legal & General Group Plc with company EPIC: LON:LGEN has increased 1.19% or 2.7 points throughout today’s trading session so far. Buyers have remained optimistic throughout the trading session. The periods high has already touched 229.4 dipping to 226. The number of shares traded by this point in time totalled 2,560,539 whilst the average number of shares exchanged is 21,919,358. The 52 week high price for the shares is 289.45 equating to 62.95 points difference from the previous close and the 52 week low at 222.7 which is a difference of 3.80 points. Legal & General Group Plc has a 20 day moving average of 239.86 and a 50 day SMA of 247.55. The market capitalisation is now £13,661.73m at the time of this report. The share price is in Great British pence. Mcap is measured in GBP. This article was written with the last trade for Legal & General Group Plc being recorded at Wednesday, December 19, 2018 at 12:02:59 PM GMT with the stock price trading at 229.2 GBX.

 

Stock in Burberry Group plc with ticker code: LON:BRBY has climbed 1.63% or 28 points in today’s trading session so far. Market buyers have remained optimistic during the session. Range high for the period has seen 1749 and a low of 1716. The amount of shares exchanged has so far reached 244,871 while the average shares exchanged is 2,330,106. The 52 week high is 2338 equating to 617 points difference from the previous days close and the 52 week low at 1481.5 making a difference of 239.5 points. Burberry Group plc now has a 20 moving average of 1806.33 and also a 50 day moving average now at 1801.21. This puts the market cap at £7,194.93m at the time of this report. The currency for this stock is Great British pence.Market cap is measured in GBP. This article was written with the last trade for Burberry Group plc being recorded at Wednesday, December 19, 2018 at 12:03:30 PM GMT with the stock price trading at 1749 GBX.

 

Shares of Whitbread plc found using EPIC: LON:WTB has gained 1.23% or 54.79 points during today’s session so far. Traders seem confident while the stock has been in play. The period high was 4502 meanwhile the session low reached 4440. The total volume of shares exchanged so far has reached 61,693 with the daily average traded share volume around 693,574. The 52 week high for the share price is 4800 which comes in at 353 points in difference on the previous days close and a 52 week low being 3606 a difference of some 841 points. Whitbread plc now has a 20 SMA of 4616.95 and the 50 day MA at 4592.96. The current market capitalisation is £8,266.96m at the time of this report. Share price is traded in GBX. Mcap is measured in GBP. This article was written with the last trade for Whitbread plc being recorded at Wednesday, December 19, 2018 at 12:03:22 PM GMT with the stock price trading at 4501.79 GBX.

 

The share price for Shire PLC company symbol: LON:SHP has increased 1.69% or 74 points throughout the session so far. Market buyers have so far held a positive outlook during the session. The periods high has reached 4471.5 while the low for the session was 4403.5. Volume total for shares traded during this period was 2,645,527 whilst the average number of shares exchanged is 6,495,982. The 52 week high for the shares is 4827.75 around 456.75 points difference from the previous days close and the 52 week low at 2940.5 is a variance of 1430.5 points. Shire PLC now has a 20 moving average of 4592.73 and the 50 day SMA of 4572.86. The market capitalisation currently stands at £40,762.22m at the time of this report. Share price is traded in GBX. Mcap is measured in GBP. This article was written with the last trade for Shire PLC being recorded at Wednesday, December 19, 2018 at 12:03:35 PM GMT with the stock price trading at 4445 GBX.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:
    GSK's Arexvy vaccine receives approval in Japan to protect adults aged 50-59 at increased risk from severe RSV infection, expanding its coverage.
    GSK Plc reports Q3 2024 results with strong growth in Specialty Medicines offsetting lower Vaccine sales. Core earnings rose by 5%, despite Zantac charges.
    GSK's new antibiotic gepotidacin earns FDA's Priority Review, marking potential first new uUTI oral treatment in 20 years, with decision due March 2025.

      Search

      Search